These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38381245)

  • 1. MM165 - A Small Hybrid Molecule Modulates the Kynurenine Pathway and Attenuates Lipopolysaccharide-Induced Memory Deficits and Inflammation.
    Kotańska M; Łanocha M; Bednarski M; Marcinkowska M
    Neurochem Res; 2024 May; 49(5):1200-1211. PubMed ID: 38381245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study.
    Kruse JL; Cho JH; Olmstead R; Hwang L; Faull K; Eisenberger NI; Irwin MR
    Psychoneuroendocrinology; 2019 Nov; 109():104371. PubMed ID: 31325802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.
    Savitz J
    Curr Top Behav Neurosci; 2017; 31():249-267. PubMed ID: 27221627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.
    Larsson MK; Faka A; Bhat M; Imbeault S; Goiny M; Orhan F; Oliveros A; Ståhl S; Liu XC; Choi DS; Sandberg K; Engberg G; Schwieler L; Erhardt S
    Neurochem Res; 2016 Sep; 41(9):2243-55. PubMed ID: 27165635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
    Badawy AA
    Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia.
    Brum M; Nieberler M; Kehrwald C; Knopf K; Brunkhorst-Kanaan N; Etyemez S; Allers KA; Bittner RA; Slattery DA; McNeill RV; Reif A; Kittel-Schneider S
    World J Biol Psychiatry; 2023; 24(7):564-577. PubMed ID: 36648064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
    Fukushima T; Umino M; Sakamoto T; Onozato M
    Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
    Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
    Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome.
    Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central kynurenine pathway shift with age in women.
    de Bie J; Guest J; Guillemin GJ; Grant R
    J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
    Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
    Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
    Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
    J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism and Markers of Systemic Inflammation in People With Human Immunodeficiency Virus.
    Gelpi M; Ueland PM; Trøseid M; Mocroft A; Lebech AM; Ullum H; Midttun Ø; Lundgren J; Nielsen SD
    J Infect Dis; 2020 Jan; 221(3):419-427. PubMed ID: 31538186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.